Skip to main content
Premium Trial:

Request an Annual Quote

Question Time

The Reddit commentariat is a tough crowd — even, it turns out, for a Nobel laureate.

Randy Schekman, who shared this year's Nobel Prize in Physiology or Medicine for his work on cell transport, took to the website yesterday for an "Ask Me Anything" session, subjecting himself to slings and arrows of the Reddit crowd.

Much of the discussion revolved around Schekman's recent announcement that his lab would no longer be publishing in "luxury" journals like Science, Nature, and Cell. As more than one commenter pointed out — and as Schekman himself admitted — this isn't an especially bold stand for someone who just won the Nobel.

A number of commenters also noted that Schekman's anti-luxury journal stance is perhaps not entirely disinterested given his role as editor of the open-access journal eLife.

"I think it's also slightly self-serving for you to try to spearhead a movement away from big name journals, when you are the editor of a new journal," one says.

And then, of course, there was wordplay:

"You were the editor of PNAS? How many jokes were made involving the name?"

Keep it classy, Redditors.

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.